Its a sample size of 1, of course its ancedotal. Its a promising first sign, but that's all. I think you have unrealistic expectations if you expect rigorus sc

Its a sample size of 1, of course its ancedotal. Its a promising first sign, but that's all. I think you have unrealistic expectations if you expect rigorus science on the cost/benefit after just one experimental procedure. Stuff like this takes time. The mere fact he didn't die from the procedure is probably a success in and of itself.